Neurocrine Biosciences (NBIX) Net Margin Growth (1y) (2011 - 2026)
Neurocrine Biosciences (NBIX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 372.00 |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | -82.00 |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | -538.00 |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | 323.00 |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | 9,881.00 |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | 2,292.00 |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | -146.00 |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | - |
| 10 | Vireo Growth | 10.64 Bn | 10.52 Bn | 59.30 Mn | 534.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,292.00 |
| Dec 31, 2025 | 266.00 |
| Sep 30, 2025 | 549.00 |
| Jun 30, 2025 | 462.00 |
| Mar 31, 2025 | -704.00 |
| Dec 31, 2024 | -1,224.00 |
| Sep 30, 2024 | 420.00 |
| Jun 30, 2024 | -1,008.00 |
| Mar 31, 2024 | 2,664.00 |
| Dec 31, 2023 | 707.00 |
| Sep 30, 2023 | -100.00 |
| Jun 30, 2023 | 10,560.00 |
| Mar 31, 2023 | -2,270.00 |
| Dec 31, 2022 | 2,394.00 |
| Sep 30, 2022 | 1,006.00 |
| Jun 30, 2022 | -9,914.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | -14,268.00 |
| Sep 30, 2021 | 2,988.00 |
| Jun 30, 2021 | -1,168.00 |